About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportSan Francisco, CA., July 28, 2017 — McKesson Corporation (NYSE:MCK) today announced results from its recent proxy vote, available in the Form 8-K filed with the Securities and Exchange Commission. McKesson’s shareholders reelected all board members by wide margins. While the shareholders did not support the current executive compensation program, they defeated shareholder proposals on an independent chair and on written consent by significant margins.
Chief Executive Officer and Chairman John H. Hammergren received strong support from shareholders as the chair of the Board with a 96.5% approval and with the defeat of the shareholder proposal to split the CEO and chair roles.
Regarding executive compensation, the Board’s Compensation Committee plans to conduct a thorough review of the current program, have discussions with shareholders about any recommended changes and, as evidenced over the years, continue to make changes designed to further drive alignment between our incentives and shareholder value creation.
“We value our shareholders’ feedback as we work to deliver ever-increasing value to our investors and our customers,” said Mr. Hammergren. “I am incredibly proud of the 70,000 McKesson employees who work every day to deliver better health to our customers and the patients they serve.”
About McKesson Corporation
McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful—all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.McKesson.com.